Literature DB >> 26646666

Fluorescent Bisphosphonate and Carboxyphosphonate Probes: A Versatile Imaging Toolkit for Applications in Bone Biology and Biomedicine.

Shuting Sun1,2, Katarzyna M Błażewska1,3, Anastasia P Kadina1, Boris A Kashemirov1, Xuchen Duan4, James T Triffitt4, James E Dunford4, R Graham G Russell4, Frank H Ebetino2, Anke J Roelofs5, Fraser P Coxon5, Mark W Lundy2, Charles E McKenna1.   

Abstract

A bone imaging toolkit of 21 fluorescent probes with variable spectroscopic properties, bone mineral binding affinities, and antiprenylation activities has been created, including a novel linking strategy. The linking chemistry allows attachment of a diverse selection of dyes fluorescent in the visible to near-infrared range to any of the three clinically important heterocyclic bisphosphonate bone drugs (risedronate, zoledronate, and minodronate or their analogues). The resultant suite of conjugates offers multiple options to "mix and match" parent drug structure, fluorescence emission wavelength, relative bone affinity, and presence or absence of antiprenylation activity, for bone-related imaging applications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26646666      PMCID: PMC5117111          DOI: 10.1021/acs.bioconjchem.5b00369

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  47 in total

Review 1.  The relationship between the chemistry and biological activity of the bisphosphonates.

Authors:  Frank H Ebetino; Anne-Marie L Hogan; Shuting Sun; Maria K Tsoumpra; Xuchen Duan; James T Triffitt; Aaron A Kwaasi; James E Dunford; Bobby L Barnett; Udo Oppermann; Mark W Lundy; Alan Boyde; Boris A Kashemirov; Charles E McKenna; R Graham G Russell
Journal:  Bone       Date:  2011-04-09       Impact factor: 4.398

Review 2.  Osteonecrosis of the jaw: who gets it, and why?

Authors:  Ian R Reid
Journal:  Bone       Date:  2008-10-07       Impact factor: 4.398

Review 3.  Near-infrared fluorescence: application to in vivo molecular imaging.

Authors:  Scott A Hilderbrand; Ralph Weissleder
Journal:  Curr Opin Chem Biol       Date:  2009-10-30       Impact factor: 8.822

4.  Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis.

Authors:  Keith Thompson; Michael J Rogers; Fraser P Coxon; Julie C Crockett
Journal:  Mol Pharmacol       Date:  2006-02-24       Impact factor: 4.436

5.  Reduced aggregation and improved specificity of G-rich oligodeoxyribonucleotides containing pyrazolo[3,4-d]pyrimidine guanine bases.

Authors:  Igor V Kutyavin; Sergey G Lokhov; Irina A Afonina; Robert Dempcy; Alexander A Gall; Vladimir V Gorn; Eugene Lukhtanov; Mark Metcalf; Alan Mills; Michael W Reed; Sylvia Sanders; Irina Shishkina; Nicolaas M J Vermeulen
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

6.  Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages.

Authors:  S P Luckman; F P Coxon; F H Ebetino; R G Russell; M J Rogers
Journal:  J Bone Miner Res       Date:  1998-11       Impact factor: 6.741

7.  A novel method of imaging calcium urolithiasis using fluorescence.

Authors:  Jose Luiz Figueiredo; Carlo C Passerotti; Todd Sponholtz; Hiep T Nguyen; Ralph Weissleder
Journal:  J Urol       Date:  2008-03-04       Impact factor: 7.450

Review 8.  Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?

Authors:  Allauddin Siddiqi; Alan G T Payne; Sobia Zafar
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-07-01

9.  Jaw bone marrow-derived osteoclast precursors internalize more bisphosphonate than long-bone marrow precursors.

Authors:  Jenny A F Vermeer; Ineke D C Jansen; Matangi Marthi; Fraser P Coxon; Charles E McKenna; Shuting Sun; Teun J de Vries; Vincent Everts
Journal:  Bone       Date:  2013-08-17       Impact factor: 4.398

10.  Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo.

Authors:  Anke J Roelofs; Fraser P Coxon; Frank H Ebetino; Mark W Lundy; Zachary J Henneman; George H Nancollas; Shuting Sun; Katarzyna M Blazewska; Joy Lynn F Bala; Boris A Kashemirov; Aysha B Khalid; Charles E McKenna; Michael J Rogers
Journal:  J Bone Miner Res       Date:  2010-03       Impact factor: 6.741

View more
  15 in total

1.  A GTPase-activating protein-binding protein (G3BP1)/antiviral protein relay conveys arteriosclerotic Wnt signals in aortic smooth muscle cells.

Authors:  Bindu Ramachandran; John N Stabley; Su-Li Cheng; Abraham S Behrmann; Austin Gay; Li Li; Megan Mead; Julia Kozlitina; Andrew Lemoff; Hamid Mirzaei; Zhijian Chen; Dwight A Towler
Journal:  J Biol Chem       Date:  2018-04-06       Impact factor: 5.157

2.  Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.

Authors:  Akishige Hokugo; Keiichi Kanayama; Shuting Sun; Kenzo Morinaga; Yujie Sun; QingQing Wu; Hodaka Sasaki; Hiroko Okawa; Courtney Evans; Frank H Ebetino; Mark W Lundy; Keivan Sadrerafi; Charles E McKenna; Ichiro Nishimura
Journal:  Bone       Date:  2019-03-26       Impact factor: 4.398

Review 3.  Near-Infrared Contrast Agents for Bone-Targeted Imaging.

Authors:  Jin Seok Jung; Danbi Jo; Gayoung Jo; Hoon Hyun
Journal:  Tissue Eng Regen Med       Date:  2019-08-19       Impact factor: 4.169

4.  Pre-Assembly of Near-Infrared Fluorescent Multivalent Molecular Probes for Biological Imaging.

Authors:  Evan M Peck; Paul M Battles; Douglas R Rice; Felicia M Roland; Kathryn A Norquest; Bradley D Smith
Journal:  Bioconjug Chem       Date:  2016-04-27       Impact factor: 4.774

5.  Reverse Microemulsion-Based Synthesis of (Bis)phosphonate-Metal Materials with Controllable Physical Properties: An Example Using Zoledronic Acid-Calcium Complexes.

Authors:  Xu Li; Youssef W Naguib; Solange Valdes; Stephanie Hufnagel; Zhengrong Cui
Journal:  ACS Appl Mater Interfaces       Date:  2017-04-13       Impact factor: 9.229

6.  In vivo distribution of zoledronic acid in a bisphosphonate-metal complex-based nanoparticle formulation synthesized by a reverse microemulsion method.

Authors:  Xu Li; Youssef W Naguib; Zhengrong Cui
Journal:  Int J Pharm       Date:  2017-04-26       Impact factor: 5.875

7.  An Acid-Activatable Fluorescence Probe for Imaging Osteocytic Bone Resorption Activity in Deep Bone Cavities.

Authors:  Ryu Hashimoto; Masafumi Minoshima; Junichi Kikuta; Shinya Yari; Steven D Bull; Masaru Ishii; Kazuya Kikuchi
Journal:  Angew Chem Int Ed Engl       Date:  2020-09-08       Impact factor: 15.336

8.  Zoledronic Acid-containing Nanoparticles With Minimum Premature Release Show Enhanced Activity Against Extraskeletal Tumor.

Authors:  Xu Li; Solange A Valdes; Riyad F Alzhrani; Stephanie Hufnagel; Stephen D Hursting; Zhengrong Cui
Journal:  ACS Appl Mater Interfaces       Date:  2019-02-11       Impact factor: 9.229

9.  Bisphosphonate-Linked TrkB Agonist: Cochlea-Targeted Delivery of a Neurotrophic Agent as a Strategy for the Treatment of Hearing Loss.

Authors:  Judith S Kempfle; Kim Nguyen; Christine Hamadani; Nicholas Koen; Albert S Edge; Boris A Kashemirov; David H Jung; Charles E McKenna
Journal:  Bioconjug Chem       Date:  2018-02-27       Impact factor: 4.774

Review 10.  Bisphosphonate conjugation for bone specific drug targeting.

Authors:  Kristen B Farrell; Alexander Karpeisky; Douglas H Thamm; Shawn Zinnen
Journal:  Bone Rep       Date:  2018-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.